<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0117">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Sun</surname>
    <given-names>X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>Z</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2019</year>). 
  <article-title>Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention</article-title>. 
  <source>Theranostics</source>
  <volume>9</volume>:
  <fpage>5183</fpage>–
  <lpage>99</lpage>.
  <pub-id pub-id-type="pmid">31410209</pub-id>
 </mixed-citation>
</ref>
